Journal of Clinical Research In HIV AIDS And Prevention

Aims and Scope

The Journal of Clinical Research in HIV and AIDS and Prevention (ISSN: 2324-7339) is a peer-reviewed, open access journal that publishes fundamental and applied research related to HIV/AIDS prevention, intervention and treatment. The journal provides a platform for researchers and practitioners to share their knowledge and experience and to provide a forum for researchers to discuss and disseminate scientific knowledge on the various aspects of HIV/AIDS. 

The journal spans a range of topics including public health, epidemiology, clinical medicine, health economics, biomedical sciences, health policy and health services. It also covers a wide array of topics such as psychosocial aspects of HIV/AIDS, pharmacoepidemiology, drug resistance, antiretroviral therapy, HIV co-infection and vaccine development. 

By providing unrestricted access to its content, the journal seeks to maximize the impact of research and contribute to the overall improvement of health outcomes in vulnerable populations. It also promotes a culture of scientific inquiry and encourages meaningful collaborations with key HIV/AIDS stakeholders. JCRHAP  aims to empower researchers and clinicians to share their knowledge and experiences while adhering to the highest standards of research ethics and publication integrity. 

Contributions from the following research areas are invited but not limited to the following branches:
 

• Syphilis and HIV
• Gonorrhea and HIV
• Sex education
• HIV/AIDS
• Alternative medicine
• Signs and symptoms
• Antivirals
• Economic impact
• Opportunistic Infections
• HIV vaccines
• Vaccine development
• Viral Pathogenesis
• Antiviral therapy
• Virus replication
• Vaccine research
• AIDS Dementia Complex
• Epidemiology of HIV
• Highly Active Antiretroviral Therapy
• Drug Research
• HIV Status
• Circumcision and HIV
• Prevention of HIV/AIDS
• Transmission modes
• HIV prevention strategies
• HIV treatment guidelines
• Antiretroviral therapy (ART)
• Pre-exposure prophylaxis (prep)
• Post-exposure prophylaxis (PEP)
• HIV drug resistance
• HIV testing and diagnosis
• Viral load monitoring
• CD4 count monitoring
• Opportunistic infections in HIV/AIDS patients
• Co-infections in HIV/AIDS patients
• HIV-associated malignancies
• HIV and mental health
• HIV stigma and discrimination
• HIV/AIDS and sexual health
• HIV/AIDS and reproductive health
• HIV/AIDS and maternal health
• HIV/AIDS and pediatric care
• HIV/AIDS and adolescent health
• HIV/AIDS and aging
• HIV/AIDS and nutrition
• HIV/AIDS and substance abuse
• HIV/AIDS and migration
• HIV/AIDS and gender issues
• HIV/AIDS and social determinants of health
• HIV/AIDS and human rights
• HIV/AIDS and community engagement
• HIV/AIDS and healthcare disparities
• HIV/AIDS and global health
• HIV/AIDS and vaccine development
• HIV/AIDS and cure research
• HIV/AIDS and gene therapy
• HIV/AIDS and immunotherapy
• HIV/AIDS and immune activation
• HIV/AIDS and immune reconstitution
• HIV/AIDS and drug interactions
• HIV/AIDS and adverse effects of medication
• HIV/AIDS and pharmacokinetics
• HIV/AIDS and drug development
• HIV/AIDS and drug delivery systems
• HIV/AIDS and personalized medicine
• HIV/AIDS and precision medicine
• HIV/AIDS and telemedicine
• HIV/AIDS and mhealth
• HIV/AIDS and ehealth
• HIV/AIDS and artificial intelligence
• HIV/AIDS and big data analytics
• HIV/AIDS and data privacy
• HIV/AIDS and data security
• HIV/AIDS and patient-centered care